Chiral Technologies Europe Signs Licensing Agreement with the University of Vienna
Chiral Technologies Europe (CTE) announced that it has entered into an exclusive worldwide licensing agreement with the University of Vienna, Austria. According to the agreement, CTE acquired exclusive manufacturing and marketing rights for novel Cinchona alkaloid-based zwitterion-exchange ... more
